10 results
20-F
2022 FY
EX-4.12
MDNAF
Medicenna Therapeutics Corp.
22 Jun 22
Annual report (foreign)
5:04pm
, the receipt and sufficiency of which are acknowledged by each party, the parties agree on the following terms:
ARTICLE 1 ENGAGEMENT
1.1
Employment
20-F
2022 FY
EX-4.16
MDNAF
Medicenna Therapeutics Corp.
22 Jun 22
Annual report (foreign)
5:04pm
and sufficiency of which are acknowledged by each party, the parties agree on the following terms:
ARTICLE 1 ENGAGEMENT
Employment
The Company hereby employs
20-F
2022 FY
EX-15.2
MDNAF
Medicenna Therapeutics Corp.
22 Jun 22
Annual report (foreign)
5:04pm
registered public accounting firm engagement for the purpose of preparing or issuing an audit report or performing other audit, review or attest services … not recognize the services as non-audit services at the time of the engagement; and
(c) the services are promptly brought to the attention
20-F
2022 FY
MDNAF
Medicenna Therapeutics Corp.
22 Jun 22
Annual report (foreign)
5:04pm
adopted specific policies and procedures for the engagement of non-audit services, as described in the Audit Committee Charter attached hereto as Exhibit
20-F
EX-4.8
2z1gcr480c0r84pc7k26
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.1
hkuw3jm
22 Jun 22
Current report (foreign)
8:00am
40-F
EX-99.1
msiy7y1vi
28 May 21
Annual report (Canada)
12:12pm
S-8
EX-99.1
7iuu9ds9wy
31 Jul 20
Registration of securities for employees
8:43am
F-10
EX-4.1
dp8k42ddz0y284l6i8
3 Jun 20
Registration of securities (Canada)
3:54pm
- Prev
- 1
- Next